Compare ARK Genomic Revolution ETF (ARKG) vs IQIYI Inc - ADR (IQ) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
ARK Genomic Revolution ETF vs IQIYI Inc - ADR — how do they compare? ARK Genomic Revolution ETF trades at $40.66, while IQIYI Inc - ADR trades at $1.15 (market cap $1.09B). The key difference: ARK Genomic Revolution ETF is trading nearer its 52-week high, IQIYI Inc - ADR nearer its low. Which is the better fit depends on your goals.
| ARKG | IQ | |
|---|---|---|
Sector | Sector/Thematic | Media |
52-Week High | $43.57 | $2.79 |
52-Week Low | $23.09 | $0.96 |
Market Cap | — | $1.09B |
Enterprise Value | — | $2.65B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
ARKG trades at $41.32, down 3.91% today, with a bullish technical signal driven by moving averages. Recent news highlights biotech ETF strength in June 2026, fueled by strong earnings, M&A activity, and AI-driven drug discovery optimism. Key support lies at $40, with resistance at $44.
The outlook remains positive given sector tailwinds, but risks include regulatory hurdles and market volatility. Investor sentiment is buoyed by industry growth catalysts, though selective investment approaches are noted by analysts.
IQ trades at $1.13, down 0.88% on the day, with technical indicators neutral and mixed earnings history. Revenue declined to $27.29B in 2025 with a net loss of $206.31M, though valuation ratios like P/S of 0.28 and P/B of 0.57 suggest potential undervaluation. Recent news highlights AI initiatives and leadership changes, while cash flow trends show volatility with a net inflow of $787.41M in 2025.
The outlook is cautious; analyst consensus is split with 50% buy ratings but profitability concerns persist. Risks include revenue declines, competitive pressures in streaming, and debt levels. Upside potential exists if AI-driven content strategies revive growth, but near-term volatility is likely amid earnings uncertainty.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About ARK Genomic Revolution ETF
ARKG is an actively managed ETF that invests in the genomic revolution. It focuses on companies leading in gene editing, CRISPR technology, therapeutics, and molecular diagnostics, including firms like CRISPR Therapeutics and Tempus AI.
Read more on ARKG →About IQIYI Inc - ADR
iQIYI Inc is an online entertainment service provider in China. It is primarily engaged in providing a variety of services encompassing internet video, live broadcasting, online games, online literature, animations, e-commerce, and social media platform. The company produces original video content and distributes appealing professionally produced content, partner-generated content, and user-generated content. It also offers a diverse collection of internet video content that appeals to users from broad demographics. The company's revenue is generated from membership services and online advertising services. The company earns most of its revenue from China.
Read more on IQ →
